Maureen Daigler-Kluge
Family · Englewood, CONPI 1992115596
Payments from drug & device makers
Across 59 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$409
- Acadia Pharmaceuticals Inc$118
- Boehringer Ingelheim$117
- Astellas Pharma US Inc$94
- GSK$62
- Novartis$41
- plus $308 from 15 others
What the payments were for
- Food & beverage$1,05592%
- Education$948%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $409 |
| Acadia Pharmaceuticals Inc | 2 | $118 |
| Boehringer Ingelheim | 6 | $117 |
| Astellas Pharma US Inc | 1 | $94 |
| GSK | 4 | $62 |
| Novartis | 3 | $41 |
| Amgen(2 entities) | 2 | $38 |
| Bayer | 2 | $36 |
| Lilly USA, LLC | 2 | $27 |
| Boston Scientific | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Indivior Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Vivus LLC | 1 | $19 |
| Merck | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Abbott | 1 | $12 |
| Nevro Corp. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Corium, LLC | 2 | $9 |
How this compares
$1,149 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $28,176 |
| RexultiBrexpiprazole | 14 | $21,293 |
| XareltoRivaroxaban | 22 | $12,531 |
| LinzessLinaclotide | 11 | $6,225 |
| MyrbetriqMirabegron | 12 | $6,171 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,524 |
| Methenamine Hippurate | 17 | $1,465 |
| Citalopram HbrCitalopram Hydrobromide | 25 | $1,450 |
| Memantine Hcl | 46 | $1,272 |
| Mirtazapine | 52 | $1,100 |
| Solifenacin Succinate | 13 | $1,042 |
| Levothyroxine Sodium | 75 | $1,016 |
| Potassium Chloride | 54 | $768 |
| Tamsulosin Hcl | 21 | $757 |
| Gabapentin | 51 | $740 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $21 | $21,29314 claims |
| AbbVieLinzess | $409 | $6,22511 claims |
| Astellas Pharma US IncMyrbetriq | $94 | $6,17112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,182 family providers in Colorado.
Other family in Englewood
- Taylor CampbellEnglewood$16K
- Meagan MurgelEnglewood$11K
- Jennifer BurkeEnglewood$9K
- Brook KilianEnglewood$8K
- Annette WychgramEnglewood$8K
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.